Carticel (Genzyme Corporation)
Welcome to the PulseAid listing for the Carticel drug offered from Genzyme Corporation. This Autologous Cultured Cell [EPC],Cells, Cultured, Autologous [Chemical/Ingredient],Chondrocytes [Chemical/Ingredient] pharmaceutical is classified as a CELLULAR THERAPY. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same CELLULAR THERAPY drug type category.
| LABELER NAME / MANUFACTURER: | Genzyme Corporation |
| NON-PROPRIETARY NAME: | autologous cultured chondrocytes |
| SUBSTANCE NAME: | AUTOLOGOUS CULTURED CHONDROCYTES |
| TYPE: | CELLULAR THERAPY |
| PHARMA CLASS: | Autologous Cultured Cell [EPC],Cells, Cultured, Autologous [Chemical/Ingredient],Chondrocytes [Chemical/Ingredient] |
| ROUTE: | INTRA-ARTICULAR |
| DOSAGE FORM: | IMPLANT |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 1997-08-22 |
| END MARKETING DATE: | 0000-00-00 |
Carticel CELLULAR THERAPY Details:
| Item Description | Carticel from Genzyme Corporation |
| LABELER NAME: | Genzyme Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 12000000(1-Jan) |
| START MARKETING DATE: | 1997-08-22 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 58468-1025_4e992833-70ee-4307-9d51-5a351ed92e9d |
| PRODUCT NDC: | 58468-1025 |
| APPLICATION NUMBER: | BLA103661 |
Other AUTOLOGOUS CULTURED CHONDROCYTES Pharmaceutical Manufacturers / Labelers:
